证券代码：000615 证券简称：*ST美谷 公告编号：2025-073 奥园美谷科技股份有限公司 第十一届董事会第二十五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 审议通过了《2025 年半年度报告全文及摘要》 经审议，董事会认为：公司《2025 年半年度报告全文》及摘要的编制程序 符合法律、行政法规、中国证监会和深圳证券交易所的相关规定，报告内容真实、 准确、完整地反映了公司的实际情况，不存在虚假记载、误导性陈述或者重大遗 漏。具体内容详见同日刊登于《证券时报》和巨潮资讯网（www.cninfo.com.cn， 下同）的《2025 年半年度报告摘要》及巨潮资讯网的《2025 年半年度报告全文》。 表决结果：9 票同意，0 票反对，0 票弃权。 特此公告。 奥园美谷科技股份有限公司 董事会 二〇二五年八月二十六日 1 奥园美谷科技股份有限公司（以下简称"公司"）第十一届董事会第二十五 次会议通知于 2025 年 8 月 16 日上午以电子通讯方式通知公司全体董事，会议于 2025 年 8 月 26 日上午以现场结合电子通讯方式召开。本次会 ...

Market Overview - The medical beauty sector experienced a decline of 3.11% on August 27, with Aimeike leading the drop [1] - The Shanghai Composite Index closed at 3800.35, down 1.76%, while the Shenzhen Component Index closed at 12295.07, down 1.43% [1] Individual Stock Performance - Aimeike (300896) closed at 190.03, down 3.88%, with a trading volume of 62,200 shares and a transaction value of 1.207 billion yuan [1] - Huaxi Biological (688363) closed at 56.87, down 2.25%, with a trading volume of 99,400 shares and a transaction value of 580 million yuan [1] - Jinbo Biological (832982) closed at 304.80, down 3.24%, with a trading volume of 10,300 shares and a transaction value of 319 million yuan [1] - ST Meigu (000615) remained unchanged at 3.33, with a trading volume of 142,300 shares and a transaction value of 47.7013 million yuan [1] Capital Flow Analysis - The medical beauty sector saw a net outflow of 199 million yuan from main funds, while retail investors contributed a net inflow of 153 million yuan [1] - Aimeike experienced a net outflow of 143 million yuan from main funds, with retail investors contributing a net inflow of 98.8281 million yuan [2] - Huaxi Biological had a net outflow of 57.973 million yuan from main funds, but a net inflow of 53.4443 million yuan from retail investors [2]

Market Overview - The Shanghai Composite Index is at 3884.87 points, above the six-month moving average, with a slight increase of 0.03% [1] - The total trading volume of A-shares today is 21,403.55 billion yuan [1] Stocks Breaking Six-Month Moving Average - A total of 47 A-shares have surpassed the six-month moving average today [1] - Notable stocks with significant deviation rates include: - Haosheng Electronics (12.03%) - Senqilin (4.06%) - Shuguang Co., Ltd. (3.72%) [1] Stock Performance Data - The following stocks have notable performance metrics: - Haosheng Electronics: Today's increase of 14.32%, turnover rate of 7.33%, six-month average price of 21.38 yuan, latest price at 23.95 yuan [1] - Senqilin: Today's increase of 5.90%, turnover rate of 6.52%, six-month average price of 20.00 yuan, latest price at 20.81 yuan [1] - Shuguang Co., Ltd.: Today's increase of 5.15%, turnover rate of 10.89%, six-month average price of 3.74 yuan, latest price at 3.88 yuan [1]

Market Overview - The Shanghai Composite Index closed at 3888.00 points, above the six-month moving average, with a slight increase of 0.11% [1] - The total trading volume of A-shares reached 16993.57 billion yuan [1] Stocks Breaking the Six-Month Moving Average - A total of 46 A-shares have surpassed the six-month moving average today, with notable stocks including Shuguang Co., Zhengdan Co., and Dongbai Group, showing divergence rates of 4.78%, 4.68%, and 2.88% respectively [1] - Stocks with smaller divergence rates that have just crossed the six-month moving average include Jinjiang Hotels, Mingchen Health, and Spring Airlines [1] Top Stocks by Divergence Rate - The top three stocks with the highest divergence rates are: - Shuguang Co. (600303) with a price increase of 6.23%, turnover rate of 9.78%, six-month line at 3.74 yuan, latest price at 3.92 yuan, and a divergence rate of 4.78% [1] - Zhengdan Co. (300641) with a price increase of 6.11%, turnover rate of 6.57%, six-month line at 24.40 yuan, latest price at 25.54 yuan, and a divergence rate of 4.68% [1] - Dongbai Group (600693) with a price increase of 3.53%, turnover rate of 5.38%, six-month line at 6.27 yuan, latest price at 6.45 yuan, and a divergence rate of 2.88% [1] Additional Stocks with Notable Performance - Other stocks with significant performance include: - Tianbang Food (002124) with a price increase of 3.30%, turnover rate of 4.80%, six-month line at 3.05 yuan, latest price at 3.13 yuan, and a divergence rate of 2.74% [1] - *ST Haiyuan (002529) with a price increase of 5.06%, turnover rate of 1.38%, six-month line at 6.68 yuan, latest price at 6.85 yuan, and a divergence rate of 2.53% [1] - Senqilin (002984) with a price increase of 4.22%, turnover rate of 4.06%, six-month line at 20.00 yuan, latest price at 20.48 yuan, and a divergence rate of 2.43% [1]

Group 1 - The medical beauty sector increased by 0.48% on August 25, with Huaxi Biological leading the gains [1] - The Shanghai Composite Index closed at 3883.56, up 1.51%, while the Shenzhen Component Index closed at 12441.07, up 2.26% [1] - The trading volume and turnover for key stocks in the medical beauty sector were reported, with Aimeike and Huaxi Biological showing notable figures [1] Group 2 - The net inflow of main funds in the medical beauty sector was 11.25 million yuan, while retail investors saw a net inflow of 37.19 million yuan [1] - Aimeike had a main fund net inflow of 5.73 million yuan, but a significant outflow from speculative funds of 36.09 million yuan [2] - Huaxi Biological experienced a main fund net inflow of 4.79 million yuan, with a minor outflow from speculative funds [2]

Group 1 - The core viewpoint of the article highlights the fluctuating investment and financing trends in China's medical beauty industry, with a peak in 2016 and a decline thereafter [1][17] - Investment events peaked in 2016 with 19 occurrences and an investment amount of 1.353 billion RMB, while the highest investment amount was recorded in 2018 at 2.374 billion RMB [1] - By 2024, only 3 investment events occurred with a total investment of 150 million RMB, and as of June 5, 2025, only 1 event with an investment of 30 million RMB was reported [1] Group 2 - The majority of investment rounds in the medical beauty industry are concentrated in early stages, particularly angel and A-round financing [2] - The industry encompasses various fields such as medical beauty raw materials, equipment, and service platforms, indicating strong innovation and technical barriers [2] Group 3 - Investment activities are primarily concentrated in Beijing and Guangdong, with 49 and 23 financing events respectively, followed by Sichuan and Shanghai with 12 and 9 events [4] - The focus on these regions is attributed to the concentration of resources and opportunities in the medical beauty sector [4] Group 4 - The investment direction is primarily focused on the construction of medical beauty platforms [6] Group 5 - The main investment entities in the medical beauty industry are capital organizations, accounting for 73% of the total, while industrial entities like Gree Electric and Xiaomi Group make up 27% [5] Group 6 - There are few industry investment funds specifically targeting medical beauty, with only 2 private funds identified [13] Group 7 - Recent years have seen a trend of horizontal acquisitions among midstream enterprises in the medical beauty industry as a means to expand scale [15] - Notable acquisition events include 康哲药业 acquiring 旭俐医疗 with a 100% stake and 新氧 acquiring 奇致激光 [16] Group 8 - Overall, the investment and financing landscape in China's medical beauty industry has shown fluctuations, with a concentration of activities in Beijing and Guangdong, primarily driven by capital investment institutions [17]

奥园美谷科技股份有限公司 证券代码：000615 证券简称：*ST美谷 公告编号：2025-072 公司对此次调整定期报告披露时间给投资者带来的不便致以诚挚的歉意，敬 请广大投资者谅解。 奥园美谷科技股份有限公司 关于延期披露 2025 年半年度报告的公告 董事会 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 二〇二五年八月二十二日 奥园美谷科技股份有限公司（以下简称"公司"）原定于 2025 年 8 月 26 日披露《2025 年半年度报告》，为进一步完善半年度报告编制和复核的相关工 作，确保半年度报告披露的真实性、准确性和完整性，基于谨慎考虑，经向深圳 证券交易所申请，公司将《2025 年半年度报告》的披露时间延期至 2025 年 8 月 28 日。 1 公司指定的信息披露媒体为《证券时报》和巨潮资讯网（www.cninfo.com.cn）， 有关信息均以公司在前述指定媒体刊登的公告为准，敬请广大投资者谨慎决策， 注意投资风险。 特此公告。 ...

证券之星消息，8月22日医疗美容板块较上一交易日上涨0.94%，爱美客领涨。当日上证指数报收于 3825.76，上涨1.45%。深证成指报收于12166.06，上涨2.07%。医疗美容板块个股涨跌见下表： 从资金流向上来看，当日医疗美容板块主力资金净流出1537.43万元，游资资金净流入1006.26万元，散 户资金净流入531.18万元。医疗美容板块个股资金流向见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 300896 | 爱美客 | 192.58 | 1.83% | 4.95万 | 9.44 G | | 688363 | 华熙生物 | 56.78 | -0.21% | 6.75万 | 3.80 Z | | 000615 | *ST美谷 | 3.24 | -0.61% | 8.72万 | 2826.63万 | | 832982 | 锦波生物 | 319.80 ...

Group 1 - The medical beauty sector increased by 1.37% on August 21, with Jinbo Biological leading the gains [1] - The Shanghai Composite Index closed at 3771.1, up 0.13%, while the Shenzhen Component Index closed at 11919.76, down 0.06% [1] Group 2 - The medical beauty sector saw a net inflow of 457,400 yuan from main funds, while retail investors experienced a net outflow of 859,410 yuan [2] - Specific stock performances included Huaxi Biological with a net inflow of 7,907,300 yuan, while *ST Meigu and Aimeike had net outflows of 3,103,300 yuan and 4,346,600 yuan respectively [2]

奥园美谷科技股份有限公司 关于新增诉讼和仲裁的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 1、本次案件所处的阶段：立案受理； 证券代码：000615 证券简称：*ST美谷 公告编号：2025-071 （一）诉讼案件基本情况 2、所处的当事人地位：被告、被申请人； 3、案件涉案金额：约 6,000.65 万元（诉讼）、约 444.67 万元（仲裁）； 4、对上市公司损益产生的影响：公司将根据企业会计准则的相关规定和案 件等情况进行财务处理，具体处理结果以及对公司本期期末业绩的影响，以会计 师事务所最终年度审计结果为准； 5、敬请广大投资者关注风险提示内容，谨慎决策、注意投资风险。 奥园美谷科技股份有限公司（以下简称"公司""奥园美谷"）于近日收到 杭州市上城区人民法院送达的传票和应诉通知书，具体诉讼情况如下： 一、本次案件的基本情况 1、案由 融资租赁合同纠纷 受理法院：杭州市上城区人民法院，案号：（2025）浙 0102 民初 20470 号 2、案件原告和被告 （2）判令被告一向原告支付合同编号为 ZY2021SH0178 的《融资租赁 ...